METASTATIC HEAD AND NECK CANCER
Clinical trials for METASTATIC HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes on HPV-driven head and neck cancer in phase 2 trial
Disease control CompletedThis study tested whether adding an experimental immunotherapy (PDS0101) to the approved drug pembrolizumab (Keytruda) can shrink tumors or slow cancer growth in people with a specific type of head and neck cancer linked to HPV16. The trial enrolled 95 adults whose cancer had ret…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
New drug duo shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, duvelisib and docetaxel, in 26 people with head and neck cancer that had come back or spread and could not be cured. The goal was to see if the combo could shrink tumors. The approach is for disease control, not a cure, as ongoing man…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated May 22, 2026 14:02 UTC